Search Results - "Nij Bijvank, Sebastiaan W"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women by Nij Bijvank, Sebastiaan W., Hengst, Micky, Cornette, Jerome C., Huigen, Sigrid, Winkelen, Anne van, Edens, Mireille A., Duvekot, Johannes J.

    “…Introduction Women with severe hypertension during pregnancy require prompt stabilization with a combination of magnesium sulfate and rapidly acting…”
    Get full text
    Journal Article
  2. 2

    Nicardipine for the Treatment of Severe Hypertension in Pregnancy: A Review of the Literature by Nij Bijvank, Sebastiaan W. A, Duvekot, Johannes J

    Published in Obstetrical & gynecological survey (01-05-2010)
    “…To evaluate the efficacy and safety of intravenous nicardipine for the treatment of severe hypertension in pregnancy. Articles were identified through…”
    Get full text
    Journal Article
  3. 3

    Predictive value of a bleeding score for postpartum hemorrhage by Gillissen, Ada, van den Akker, Thomas, Caram‐Deelder, Camila, Henriquez, Dacia D.C.A., Nij Bijvank, Sebastiaan W.A., Bloemenkamp, Kitty W.M., Eikenboom, Jeroen, van der Bom, Johanna G.

    “…A reliable screening tool that could contribute to the identification of women with an increased risk of postpartum hemorrhage would be of great clinical…”
    Get full text
    Journal Article
  4. 4

    Variable cardiovascular phenotypes associated with SMAD2 pathogenic variants by Granadillo, Jorge L., Chung, Wendy K., Hecht, Leah, Corsten‐Janssen, Nicole, Wegner, Daniel, Nij Bijvank, Sebastiaan W.A., Toler, Tomi L., Pineda‐Alvarez, Daniel E., Douglas, Ganka, Murphy, Joshua J., Shimony, Joshua, Shinawi, Marwan

    Published in Human mutation (01-12-2018)
    “…SMAD2 is a downstream effector in the TGF‐β signaling pathway, which is important for pattern formation and tissue differentiation. Pathogenic variants in…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Congenital Amegakaryocytic Thrombocytopenia Type II Presenting with Multiple Central Nervous System Anomalies by Eshuis-Peters, Ellis, Versluys, Anne Brigitta, Stokman, Marijn Fijke, van der Crabben, Saskia Nanette, Nij Bijvank, Sebastiaan W A, van Wezel-Meijler, Gerda

    Published in Neuropediatrics (01-04-2016)
    “…Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare autosomal recessive bone marrow failure, caused by MPL gene mutations. The combination of CAMT and…”
    Get more information
    Journal Article
  10. 10